For the past 20 years Kidney Cancer UK has been a consistent, prominent and influential name working to support patients through the approval of drugs for kidney cancer patients, better treatments and a clear treatment pathway.

No matter who the faces are behind the name, the main thrust and driver of the charity has always been the welfare of patients, their carers and their families; we are here to listen, inform and support.

With an increasing number of people developing kidney cancer, treatment options have improved significantly in the last two decades, offering better survival rates worldwide. But, five-year survival rates in the UK lag behind Europe.

Twenty years on we look through the archives and back up to 2020 and look at what has changed in and for the care of kidney cancer patients.